Brief: Entera Bio Announces Full Year 2023 Financial Results
08/03/2024 21:06
March 8 (Reuters) - Entera Bio Ltd 5DT.F :
* ENTERA BIO ANNOUNCES FULL YEAR 2023 FINANCIAL RESULTS AND
PROVIDES BUSINESS UPDATES
* ENTERA BIO LTD - AS OF DECEMBER 31, 2023, ENTERA HAD CASH
AND
CASH EQUIVALENTS OF $11.0 MILLION
* ENTERA BIO LTD: FY LOSS PER SHARE $0.31
Source text for Eikon: ID:nGNX8yVvhM
Further company coverage: 5DT.F
Recent news on Entera Bio
See all newsBrief: Entera Appoints Global Pharmaceutical Leader Riccardo Paolo Camisasca, M.D., As Chief Medical Officer Ahead Of Planned Eb613 Phase 3 Initiation
Corrected: Israel's Entera Bio Q2 net loss widens
NASDAQ RESUMED AT 10:02 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 09:57 AM
Brief: Entera Bio Announces Pricing Of Oversubscribed $275 Million Private Placement